SLC22A12 and hyperuricemia: As expected, UWP, UWE, UWB, and UWA at high and low dose groups significantly reduced the expression of URAT1 in hyperuricemia mice, while UWP-L, UWP-H, UWE-L, and UWA-H remarkably increased the expression of OAT1.